Inventiva S.A. (IVA) Financials
A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Sep 12, 2026; every other figure is from the SEC filings on this page. Not financial advice.
Newest figures come from the 10-K for FY2021, filed Mar 11, 2022. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the IVA SEC filings page.
This page shows Inventiva S.A. (IVA) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. All figures are derived from SEC filings (10-K and 10-Q reports).
Financial Health Signals
Inventiva S.A. does not currently provide enough eligible data for a peer-relative financial health score, so none is published. The metrics below are current.
Key Financial Metrics
Earnings & Revenue
None of these metrics is reported for Q4 2021.
Cash & Balance Sheet
Not reported for Q4 2021.
Not reported for Q4 2021.
Not reported for Q4 2021.
Margins & Returns
None of these metrics is reported for Q4 2021.
Capital Allocation
None of these metrics is reported for Q4 2021.
IVA Income Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q4'2110-K |
|---|
Not reported in any period shown, so not listed: Revenue, Cost of Revenue, Gross Profit, R&D Expenses, SG&A Expenses, Operating Income, EBITDA, Interest Expense, Income Tax, Net Income, EPS (Basic), EPS (Diluted), Diluted Shares (Avg).
IVA Balance Sheet
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q4'2110-K |
|---|---|
| Total Assets | $122.0M |
| Total Liabilities | $33.1M |
| Total Equity | $88.9M |
Not reported in any period shown, so not listed: Current Assets, Cash & Equivalents, Short-Term Investments, Inventory, Accounts Receivable, Long-Term Investments, Goodwill, Current Liabilities, Non-Current Liabilities, Long-Term Debt, Retained Earnings.
IVA Financial Ratios
Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q4'2110-K |
|---|---|
| Debt-to-Equity | 0.37 |
Not reported in any period shown, so not listed: Gross Margin, Operating Margin, Net Margin, Return on Equity, Return on Assets, Current Ratio, Asset Turnover, FCF Margin.
Similar Companies
Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it.
| Company | Fiscal year | Revenue | Net income | Net margin | Market cap | Health score |
|---|---|---|---|---|---|---|
| Inventiva S.A. IVA | FY2021 | N/A | -$49.6M | N/A | $949.7M | — |
| Immunome Inc IMNM | FY2025 | $6.9M | -$212.4M | N/A | $2.8B | 49/100 |
| Geron Corp GERN | FY2025 | N/A | -$83.5M | N/A | $880.2M | — |
| Praxis Precision Medicines, Inc. PRAX | FY2025 | $0 | -$303.0M | N/A | $9.5B | — |
| Anavex Life Scie AVXL | FY2025 | N/A | -$46.4M | N/A | $246.6M | — |
| BridgeBio Oncology Therapeutics, Inc BBOT | FY2025 | N/A | -$134.0M | N/A | $442.6M | — |
Where Inventiva S.A. Ranks
Frequently Asked Questions
Is Inventiva S.A. profitable?
No, Inventiva S.A. (IVA) reported a net income of -$49.6M in fiscal year 2021.
What is Inventiva S.A.'s return on equity (ROE)?
Inventiva S.A. (IVA) has a return on equity of -55.9% for fiscal year 2021, measuring how efficiently the company generates profit from shareholder equity.
What are Inventiva S.A.'s total assets?
Inventiva S.A. (IVA) had $122.0M in total assets as of fiscal year 2021, including both current and long-term assets.
What is Inventiva S.A.'s debt-to-equity ratio?
Inventiva S.A. (IVA) had a debt-to-equity ratio of 0.37 as of fiscal year 2021, measuring the company's financial leverage by comparing total debt to shareholder equity.
What is Inventiva S.A.'s return on assets (ROA)?
Inventiva S.A. (IVA) had a return on assets of -40.7% for fiscal year 2021, measuring how efficiently the company uses its assets to generate profit.
What is Inventiva S.A.'s P/E ratio?
Inventiva S.A. (IVA) has no price-to-earnings ratio at the moment: net loss, so no earnings multiple (FY2021). The market capitalization is $949.7M as of Sep 12, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.
What is Inventiva S.A.'s price-to-sales ratio?
Inventiva S.A. (IVA) has no price-to-sales ratio at the moment: no revenue reported. The market capitalization is $949.7M as of Sep 12, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.